Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial) – A phase II non-randomised trial
Titel:
Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial) – A phase II non-randomised trial
Auteur:
Mitry, Emmanuel Walter, Thomas Baudin, Eric Kurtz, Jean-Emmanuel Ruszniewski, Philippe Dominguez-Tinajero, Sophie Bengrine-Lefevre, Leïla Cadiot, Guillaume Dromain, Clarisse Farace, Françoise Rougier, Philippe Ducreux, Michel